1. 078 Reductions in absolute neutrophil count with sarilumab resulting in dose delays or dose decreases: effects on efficacy and safety. (12th April 2019) Authors: Curtis, Jeffrey R; John, Gregory St; Pannucci, Michael; Lin, Yong; Maldonado-Cocco, José A; Huizinga, Thomas; Stanislav, Marina; Wilson, Elaine; Emery, Paul Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 080 Long-term treatment with sarilumab plus conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs): pooled safety and efficacy with over 4 years' treatment. (12th April 2019) Authors: van Hoogstraten, Hubert; John, Gregory St; Thangavelu, Karthinathan; Gomez-Reino, Juan Jose; Maldonado-Cocco, Jose Antonio; Salazar, Juan Carlos; Huizinga, Thomas; Wilson, Elaine; Burmester, Gerd R Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0222 ASSOCIATION BETWEEN CENTROMERE AND TOPOISOMERASE SPECIFIC IMMUNE RESPONSES AND THE DEGREE OF MICROANGIOPATHY IN SYSTEMIC SCLEROSIS. (June 2019) Authors: Leeuwen, Nina van; Bakker, Jaap; Wortel, Corrie; Scherer, Hans Ulrich; Toes, Rene; Huizinga, Thomas; Vries-Bouwstra, Jeska de Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB1282 A BIG-DATA APPROACH TO ELECTRONIC HEALTH RECORD DATA – USING DIMENSIONALITY REDUCTION AND CLUSTERING TECHNIQUES TO STUDY LONGITUDINAL RELATIONSHIPS BETWEEN DISEASES. (June 2019) Authors: Maurits, Marc; Huizinga, Thomas; Raychaudhuri, Soumya; Reinders, Marcel; Karlson, Elizabeth; Akker, Erik van den; Knevel, Rachel Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 2102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1299 AN ONGOING ANTICENTROMERE ANTIBODY RESPONSE ASSOCIATES WITH PROGRESSION TOWARDS SYSTEMIC SCLEROSIS. (June 2019) Authors: Leeuwen, Nina van; Boonstra, Maaike; Bakker, Jaap; Wortel, Corrie; Scherer, Hans Ulrich; Toes, Rene; Huizinga, Thomas; Vries-Bouwstra, Jeska de Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 2111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0081 WITHDRAWAL OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE SARILUMAB OPEN-LABEL EXTEND STUDY: EFFICACY AND SAFETY ANALYSIS. (June 2019) Authors: Curtis, Jeffrey R.; Lin, Yong; Thangavelu, Karthinathan; Stanislav, Marina; John, Gregory St.; Gómez-Centeno, Antonio; Selmi, Carlo; Huizinga, Thomas; Maldonado-Cocco, José Antonio; Bukhari, Marwan; Buttgereit, Frank Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0123 BIOLOGICAL THERAPIES SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTSIN CLINICAL PRACTICE: RESULTS FROM THE METEOR REGISTRY. (June 2019) Authors: Torrente-Segarra, Vicenç; Huizinga, Thomas; Solomon-Escoto, Karen; Da Silva, José Antonio P.; Veale, Douglas; Emadi, Samar Al; Bergstra, Sytske Anne Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0023 ACPA-POSITIVE RHEUMATOID ARTHRITIS PATIENTS BENEFITED MORE FROM ADVANCED TREATMENT STRATEGIES THAN ACPA-NEGATIVE RHEUMATOID ARTHRITISPATIENTS: 25-YEAR RESULTS OF A LONGITUDINAL COHORT STUDY. (June 2019) Authors: Matthijssen, Xanthe; Niemantsverdriet, Ellis; Huizinga, Thomas; van der Helm - van Mil, Annette Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0042 LONG-TERM EFFECTS OF SYNERGETIC B CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB COMBINATION TREATMENT IN SEVERE, REFRACTORY SLE: TWO YEAR RESULTS. (June 2019) Authors: Kraaij, Tineke; Arends, E.J.; Dam, Laura van; Kamerling, Sylvia; Daele, Paul L.A. van; Bredewold, Obbo Winne; Ray, Argho; Bakker, Jaap; Bajema, Ingeborg; Scherer, Hans Ulrich; Huizinga, Thomas; Rabelink, Ton; Kooten, Cees van; Onno Teng, Y.K. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0295 N-LINKED GLYCANS IN THE VARIABLE DOMAIN OF ACPA-IGG IN THE DEVELOPMENT OF RHEUMATOID ARTHRITIS. (June 2019) Authors: Hafkenscheid, Lise; de Moel, Emma C.; Smolik, Irene; Meng, Xiaobo; Tanner, Stacy; Jansen, Bas C.; Bondt, Albert; Wuhrer, Manfred; Huizinga, Thomas; Toes, Rene; El-Gabalawy, Hani; Scherer, Hans Ulrich Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗